Fact CheckerSign in

NCT05081115Recruiting

Stress Echo 2030: the Novel ABCDE-(FGLPR) Protocol to Define the Future of Imaging

The International Stress Echo Study to to Define the Future of Imaging

Source: ClinicalTrials.gov · Last updated 26 Oct 2021 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

With stress echo (SE) 2020 study, a new standard of practice in stress imaging was developed and disseminated: the ABCDE protocol for functional testing within and beyond CAD. ABCDE protocol was the fruit of SE 2020, and is the seed of SE 2030, which is articulated in 12 projects: 1-SE in coronary artery disease (SECAD); 2- SE in diastolic heart failure (SEDIA); 3-SE in hypertrophic cardiomyopathy (SEHCA); 4- SE post-chest radiotherapy and chemotherapy (SERA); 5- Artificial intelligence SE evaluation (AI-SEE); 6- Environmental stress echocardiography and air pollution (ESTER); 7- SE in repaired Tetralogy of Fallot (SETOF) ; 8- SE in post-COVID-19 (SECOV); 9: Recovery by stress echo of conventionally unfit donor good hearts (RESURGE); 10- SE for mitral ischemic regurgitation (SEMIR); 11- SE in valvular heart disease (SEVA); 12- SE for coronary vasospasm (SESPASM). The study aims to recruit in the next 5 years (2021-2025) ≥10 000 patients followed for ≥5 years (up to 2030) from ≥20 quality-controlled laboratories from ≥10 countries. In this COVID-19 era of sustainable health care delivery, SE2030 will provide the evidence to finally recommend SE as the optimal and versatile imaging modality for functional testing anywhere, any time and in any patient.

Status (registry)
Recruiting
Study type
Observational
Enrollment
10000 (estimated)
First submitted
4 Oct 2021
Start date
1 Apr 2021
Primary completion date
31 Dec 2022
Lead sponsor
Fatebenefratelli Hospital
NCT number
NCT05081115

What you commit to

  • Study type: Observational
  • Planned participants: 10000
  • From 1 Apr 2021 to the primary completion date, 31 Dec 2022
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • \-

Who the study is looking for

  • Known or suspected coronary artery disease Hypertrofic cardiomiopathy Repaired Tetralogy of Fallot Primary valvular disease

Age in the registry: 18 years to 75 years · Sex: All

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Fatebenefratelli Hospital
Coordinator of this site? Confirm its status
BeneventoItalyRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.